Search clinical trials for: ASLAN001 CAPOX (Oxaliplatin, capecitabine)

Total 584 results

National Cancer Centre, Singapore
National Medical Research Council (NMRC), Singapore; ASLAN Pharmaceuticals

Active, not recruiting

ASLAN001 in Combination With Oxaliplatin and Capecitabine or Oxaliplatin and 5-FU With Leucovorin

Solid Tumors

Singapore
Peking University Cancer Hospital & Institute
Peking University People's Hospital; Peking Union Medical College Hospital

Recruiting

Efficacy of Postoperative Adjuvant Chemotherapy for Stage II Colon Cancer With High Risk Factors(EPAC1) (EPAC1)

Adjuvant Chemotherapy

China
池畔

Not yet recruiting

Organ Preservation Following Enverolimab-based Total Neoadjuvant Therapy for Locally Advanced Very Low Rectal Cancer (TRACE-LE)

Rectal Cancer

China
NSABP Foundation Inc
Amgen

Withdrawn

Study of Panitumumab Given First With Capecitabine and Oxaliplatin (CAPOX) and Then With Capecitabine and Radiation of the Pelvis for Treatment of Patients With Rectal Cancers That May or May Not Have Spread Beyond the Rectum

Neoplasm Metastasis | Rectal Cancer
Fujian Medical University Union Hospital

Recruiting

Chemotherapy and Tislelizumab With Split-course HFRT for Locally Advanced Rectal Cancer

Rectal Cancer | Radiation Oncology

China
Zealand University Hospital

Recruiting

NEOadjuvant Chemotherapy Only Compared With Standard Treatment for Locally Advanced Rectal Cancer (NEOLAR)

Intestinal Neoplasms | Colorectal Cancer | Rectal Cancer | Rectal Neoplasms | Colorectal Neoplasm | Chemotherapy Effect | Intestinal Disease

Denmark
Ruijin Hospital
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Not yet recruiting

SCRT Sequential Penpulimab in Combination With CAPEOX in the Neoadjuvant Treatment of MSS Locally Advanced Rectal Cancer (N-PRC)

Rectal Cancer | Locally Advanced
University of Roma La Sapienza

Not yet recruiting

Proactive Management of Endoperitoneal Spread in Colonic Cancer (PROMENADE)

Colon Cancer | Intraperitoneal Rectal Cancer

Italy
Gustave Roussy, Cancer Campus, Grand Paris

Recruiting

Preoperative Radiotherapy And ASTX660 in Rectum Cancer (PRAAR1)

Locally-advanced Rectal Cancer

France
ASLAN Pharmaceuticals

Completed

A Study of Varlitinib in Japanese Subjects With Advanced or Metastatic Solid Tumours

Advanced or Metastatic Solid Tumors | Advanced or Metastatic Biliary Tract Cancer

Japan
Suzhou Transcenta Therapeutics Co., Ltd.

Not yet recruiting

Combination of TST001, Nivolumab and Chemotherapy as First-line Therapy in Advanced or Metastatic GC/GEJ Adenocarcinoma

Gastric Cancer | Advanced Cancer | Gastroesophageal-junction Cancer
Samsung Medical Center

Unknown

Study Investigating the Role of Oxaliplatin Duration in Modified FOLFOX-6 or CAPOX Regimen as Adjuvant Colon Cancer Therapy

Colon Cancer

Korea, Republic of
Asan Medical Center
Seoul National University Bundang Hospital; Severance Hospital; Hallym University... and other collaborators

Recruiting

Compare Adjuvant Chemotherapy of Docetaxel/Capecitabine/Oxliplatin Versus Capecitabine/Oxaliplatin in Advanced Gastric Cancer at Stage IIIb and IV(KCSG ST15-08): TRIUMPH

Gastric Cancer, Adjuvant Chemotherapy, XO

Korea, Republic of
Hallym University Medical Center
Sanofi

Completed

Oxaliplatin and S-1 (OS) Versus Oxaliplatin and Capecitabine (XELOX) for Advanced Colorectal Cancer

Colorectal Neoplasm

Korea, Republic of
Shanghai Changzheng Hospital

Not yet recruiting

Preoperative Nivolumab Plus Bevacizumab Combined With Chemotherapy Before Surgery in Patients With pMMR/MSS Colorectal Cancer Liver Metastases

Colorectal Cancer Liver Metastases
Qun Zhao
Jiangsu HengRui Medicine Co., Ltd.

Completed

Three Drugs in Advanced Gastric Cancer Neoadjuvant Chemotherapy for Stage Ⅲ Clinical Study

Gastric Cancer

China
Dutch Colorectal Cancer Group
Sanofi; Roche Pharma AG; Koningin Wilhelmina Fonds; Immunicon

Completed

Cetuximab, Capecitabine, Oxaliplatin and Bevacizumab in Advanced Colorectal Cancer

Colorectal Cancer

Netherlands
GERCOR - Multidisciplinary Oncology Cooperative...

Active, not recruiting

Combination Chemotherapy for 3 Months or 6 Months in Treating Patients With Stage III Colon Cancer (IDEA)

Colorectal Cancer

France
Samsung Medical Center
National Cancer Center, Korea; Asan Medical Center; Chonnam National University... and other collaborators

Completed

Study of S-1 and Oxaliplatin (SOX) Versus Capecitabine and Oxaliplatin (COX) in Patients With Advanced Colorectal Cancer

Colorectal Cancer

Korea, Republic of
LI XIN-XIANG

Recruiting

Adjuvant Chemotherapy in Patients With Clinical Stage III Rectal Cancer Undergoing Neoadjuvant Chemoradiotherapy

Rectal Neoplasms

China
UNC Lineberger Comprehensive Cancer Center

Withdrawn

Neoadjuvant Therapy for Localized Rectal Adenocarcinoma

Rectal Adenocarcinoma

United States
Hebei Medical University

Completed

Preoperative Concurrent Chemoradiotherapy for Potentially Resectable Adenocarcinoma of the Esophagogastric Junction (A-C)

Gastroesophageal Junction Adenocarcinoma

China
Samsung Medical Center

Completed

A Study of Pazopanib With CAPEOX in AGC Patients

Gastric Cancer

Korea, Republic of
AIO-Studien-gGmbH
iOMEDICO AG

Terminated

Study to Evaluate the Effects of Panitumumab if Combined With Chemotherapy for 2nd Treatment of Colorectal Cancer (VOXEL)

Colorectal Neoplasms

Germany
Hebei Medical University

Unknown

Preoperative Chemotherapy With Bevacizumab For Potentially Resectable Gastric Cancer With Liver Metastasis

Gastric Cancer | Liver Metastasis

China
Karen-Lise Garm Spindler

Recruiting

IMPROVE Intervention Trial Implementing Non-invasive Circulating Tumor DNA Analysis to Optimize the Operative and Postoperative Treatment for Patients With Colorectal Cancer (IMPROVE-IT)

Colorectal Cancer | Adjuvant Chemotherapy | Circulating Tumor DNA | Progression Free Survival

Denmark
Sun Yat-sen University

Enrolling by invitation

Chemotherapy Combined With High-dose Radiotherapy for Low Rectal Cancer Using MR Guided Linear Accelerator

Rectal Cancer

China
Peking University
Taiho Pharmaceutical Co., Ltd.

Unknown

Phase III Study to Compare Perioperative Chemotherapy of Oxaliplatin Combined With S-1(SOX) Versus SOX or Oxaliplatin With Capecitabine (XELOX) as Post-operative Chemotherapy in Locally Advanced Gastric Adenocarcinoma With D2 Dissection

Advanced Gastric Carcinoma

China
Hebei Medical University

Unknown

Apatinib Plus Concurrent Neoadjuvant Chemoradiotherapy for Gastroesophageal Junction

Gastroesophageal Junction Adenocarcinoma

China
ASLAN Pharmaceuticals
Syneos Health; bioRASI, LLC; CMIC Co, Ltd. Japan

Completed

Varlitinib in Combination With Capecitabine for Advanced or Metastatic Biliary Tract Cancer (TreeTopp)

Biliary Tract Cancer

United States, Australia, China, Hong Kong, Hungary, Japan, Korea, Republic of, Poland, Singapore, Spain, Taiwan
Hebei Medical University

Unknown

Perioperative Chemotherapy With Herceptin For Potentially Resectable HER-2 Positive Gastric Cancer With Liver Metastasis

Liver Metastasis | HER-2 Positive Gastric Cancer

China
Fudan University

Recruiting

Perioperative Versus Postoperative CapOX Chemotherapy for Locally Advanced Colon Cancer

Locally Advanced Colon Cancer

China
Swiss Group for Clinical Cancer Research

Completed

Capecitabine and Oxaliplatin With or Without Cetuximab in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed By Surgery

Colorectal Cancer

Switzerland
University of Southern California
Bristol-Myers Squibb; Sanofi; Roche Global Development

Unknown

Study of Oxaliplatin and Xeloda and Cetuximab as First Line Treatment for Metastatic or Unresectable Gastric or Gastroesophageal Junction Cancer

Gastric Cancer | Esophageal Cancer

United States
Royal Marsden NHS Foundation Trust

Completed

Phase II Trial Assessing Efficacy and Toxicity of Capecitabine and Oxaliplatin in the Treatment of Colorectal Cancer

Colorectal Cancer

United Kingdom
The First Affiliated Hospital of Zhengzhou University

Recruiting

Duration of Adjuvant Chemotherapy for Gastric Cancer Patients at Pathological N3 Stage

Gastric Cancer

China
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Completed

Oxaliplatin and Capecitabine in Treating Patients With Advanced Esophageal Cancer or Stomach Cancer

Gastric Cancer | Esophageal Cancer

United States
University of Louisville
James Graham Brown Cancer Center

Completed

Phase II (Treatment) Study of Oxaliplatin and Capecitabine in Advanced Head and Neck Malignancies

Head or Neck Cancer

United States
Seoul National University Hospital
National Cancer Center, Korea; Chonbuk National University Hospital; Chonnam... and other collaborators

Completed

Lymph Node Metastasis in Extended Lymphadenectomy for Gastric Cancer From a CLASSIC Trial

Stomach Neoplasms | Cancer of Lymph Node
Medical University of South Carolina

Terminated

Capecitabine and Oxaliplatin in Treating Patients With Locally Advanced, Unresectable, or Metastatic Stomach Cancer

Gastric Cancer

United States
University of Miami

Completed

Oxaliplatin and Capecitabine in Treating Patients With Relapsed or Metastatic Head and Neck Cancer

Head and Neck Cancer

United States
European Organisation for Research and Treatment...

Completed

Chemotherapy and Radiation Therapy Before Surgery Followed by Capecitabine With or Without Oxaliplatin in Treating Patients With Locally Advanced Rectal Cancer (PETACC-6)

Colorectal Cancer
City of Hope Medical Center
National Cancer Institute (NCI)

Completed

Oxaliplatin Plus Capecitabine in Treating Patients With Metastatic or Recurrent Solid Tumor

Unspecified Adult Solid Tumor, Protocol Specific

United States
Ye Xu

Unknown

Alternating Systemic and Hepatic Artery Infusion Therapy As Adjuvant Treatment After Resection of Liver Metastases From Colorectal Cancer

Resected Liver Metastases From Colorectal Cancer

China
Fudan University

Suspended

Combination of Capecitabine and Oxaliplatin in Patients With Relapsed or Refractory Gastric Cancer

Gastric Cancer

China
New Mexico Cancer Care Alliance

Completed

Gene Expression Analysis of Patients With Metastatic Colorectal Cancer Receiving Oxaliplatin Based Chemotherapy Regimen

Cancer | Colonic Diseases

United States
National Cancer Center Hospital East
Bayer Yakuhin, Ltd.

Active, not recruiting

Clinical Study of Regorafenib and Nivolumab Plus Chemotherapy

Gastric Adenocarcinoma | Esophageal Adenocarcinoma | Gastroesophageal Junction Adenocarcinoma

Japan
AIPING ZHOU

Recruiting

Toripalimab Combined With Chemotherapy as Neoadjuvant Treatment of Gastric Cancer

Gastric Cancer Stage III | Gastric Cancer Stage II

China
University of Wisconsin, Madison
Sanofi

Completed

XELOX for Metastatic Breast Cancer

Metastatic Breast Cancer

United States
Sanofi

Completed

CORE: Capecitabine, Oxaliplatin, Radiotherapy and Excision

Rectal Neoplasms

France, Spain, Belgium, Italy, United Kingdom, Germany, Netherlands

3

Subscribe